Moving Forward in Alzheimer’s Disease

New Management Paradigms for Patients and Healthcare Systems

 

Target Audience

The educational design of this activity addresses the needs of neurology, psychiatry, and gerontology specialists involved in the treatment of patients with Alzheimer’s disease (AD).

 

Statement of Need/Program Overview

Alzheimer’s disease (AD) is a common neurodegenerative condition that results in a range of profoundly disabling cognitive, affective, and behavioral symptoms. The current understanding of the complex pathophysiology of AD has led to the development of therapies that target amyloid β, tau, and neuroinflammation. Despite its prevalence and significant associated medical, psychosocial, and economic burdens, AD often remains undiagnosed and untreated. As new pathophysiology-linked biomarkers become available and incorporated into practice, diagnosis will improve, thus improving management strategies. However, newer management strategies may result in changes to infrastructure, which will impact each clinician’s practice. In this CME SnapShot series, Dr. Turner and Dr. Cohen will examine AD pathophysiology, optimal strategies to screen patients with suspected mild cognitive impairment (MCI) or AD, the differential diagnoses of MCI and AD, current evidence and regulatory status for newer targeted therapies, ongoing health care disparities in the management of these patients, and potential changes to health care systems as new treatment options become available.

This activity is jointly provided by Global Education Group and Integritas Communications.

 

This activity is supported by an educational grant from Biogen MA, Inc.

Image SnapShot
Pathophysiology of Alzheimer's Disease

Module 1

Sharon Cohen, MD; R. Scott Turner, MD, PhD
MODULE 1
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 02/17/2023

Image SnapShot
Evaluation and Diagnosis of MCI and AD

Module 2

Sharon Cohen, MD; R. Scott Turner, MD, PhD
MODULE 2
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 02/17/2023

Image SnapShot
Management of AD

Module 3

Sharon Cohen, MD; R. Scott Turner, MD, PhD
MODULE 3
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 02/17/2023

Image SnapShot
Barriers to Optimizing Alzheimer's Disease Management

Module 4

Sharon Cohen, MD; R. Scott Turner, MD, PhD
MODULE 4
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 02/17/2023

Resource

Moving Forward in Alzheimer’s Disease

New Management Paradigms for Patients and Healthcare Systems